Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




X-Ray Powder Diffraction Technology Developed for Molecule Identification

By LabMedica International staff writers
Posted on 05 Aug 2014
A Danish researcher has developed a technique that uses X-rays for the rapid identification of substances present in an indeterminate powder. More...
The new technique has the capacity to recognize sophisticated biologic molecules such as proteins. The method therefore has enormous potential in food production and the pharmaceutical industry, where it opens up, for example, new opportunities for the quality assurance (QA) of protein-based drugs. The technique was developed by a Technical University of Denmark (DTU; Kongens Lyngby) researcher.

It is rarely sufficient to read the content information if one needs to know exactly what substances a product contains. One needs to be a very skilled chemist or to have “X-ray vision” to look directly into the molecular structure of the various substances. Christian Grundahl Frankaer, a postdoc in the DTU department of chemical engineering, is almost both, as he has developed technology that allows him to use X-rays to look deep into biologic samples.

The technique is called powder diffraction and involves subjecting a sample to an intense beam of X-rays. When the beam hits the sample, it disseminates in the same manner as light does when reflected by a disco ball. This generates a pattern that reflects the structure of the substance. Each individual substance has its own unique pattern, which makes it easily identifiable when the findings are run through a database.

Powder diffraction is currently used to identify basic substances such as salts, sugars, and minerals, but the theory behind using the same technique to characterize complicated biologic molecules such as proteins is groundbreaking. It is for this reason that the technology has huge possibilities in both food production and the pharmaceutical industry, where more and more attention is being dedicated to protein-based medicines.

“I have tested different types of infant milk formula, protein powders and detergents. By taking a small sample of powder and bombarding it with X-rays, I can determine what substances the powder contains, and in what concentrations, within 10 minutes. In addition, the analysis will typically reveal some information about how the product was made,” noted Dr. Frankaer. The method is therefore perfect for quality assurance of new products on the market.

Dr. Franaer added, “We have now demonstrated that powder diffraction can actually be used on biological substances such as proteins. The results are not as detailed as in single crystal diffraction, which makes it possible to decode the entire structure of the protein, but they do allow us to ‘lift fingerprints’ quickly and easily so that we can identify the protein and its crystal structure. This is valuable knowledge when you are working with the production of proteins.”

The technology has great potential in the framework of optimizing both quality and production processes in all production set-ups that involve solid substances. Applying the new approach will make it possible to check continuously for alterations in—or transformations of—different materials used in the production process. “The advantage of our method is that it allows you to take samples directly from a production line. You then have the results within 15 minutes and can tell precisely what crystalline material is involved. In addition, the X-ray beams we use can easily be generated using standard laboratory equipment,” stated Dr. Frankaer.

The promising findings are just beginning of the project, “What we want to do now is to test how far we can push the method. We have already established that it works on proteins, but will it also work on other complex products? And what happens if we take the samples to the synchrotron in Grenoble [France], where the X-ray beam is a million times more powerful than the one we have in our laboratory?” queried Dr. Frankaer.

Related Links:

Technical University of Denmark



Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Automated Biochemical Analyzer
iBC 900
New
Modular Hemostasis Automation Solution
CN Track
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.